What is already known about this topic?
Risk factors for BKV are aggressive immunosuppression, high human
leukocyte antigen (HLA) mismatch, ureteral stent use, rejection therapy,
prolonged ischemia duration, advanced age, male recipient, diabetes
mellitus (DM), lymphocyte depleting induction therapies, tacrolimus, and
mycophenolate- based regimens.